Immunovant, Inc. (IMVT): $15.78

-0.16 (-1.00%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add IMVT to Watchlist
Sign Up

Industry: Biotech


Ranked

of NR

in industry

Immunovant Inc (IMVT) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering IMVT.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
11 $55 $26 $38.55 $16.56 132.79%

IMVT Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.36 4 6 1 0 0 11

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • Immunovant Inc's upside potential (average analyst target price relative to current price) is higher than 90.5% of all US stocks.
  • IMVT has a lower variance in analysts' estimates than 12.28% of all US stocks.
  • IMVT has a greater number of analysts covering the stock than 87.24% of Pharmaceutical Products stocks.
  • The average analyst price target of IMVT is higher than 70.33% of Pharmaceutical Products stocks.
  • The NA of IMVT is higher than just about none of of all US stocks.

Stocks similar to Immunovant Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ALDX, KPTI and CBAY.

Is IMVT a Buy, Hold or Sell? See the POWR Ratings now!



Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.605 seconds.